Refractory disease, new horizons and patient-physician relationships
Related Experiment Videos
L M Glode1, D P Petrylak, L M Glode
1University of Colorado Cancer Center, Denver, Colorado.
Abstract:
Understanding the role of chemotherapy for prostate cancer has advanced along two axes, better definition of endpoints, and biologic understanding of disease targets. Use of PSA as a surrogate endpoint makes possible the more rational design of phase III trials which will include survival and disease free intervals as an endpoint. Pain control has emerged as an important treatment endpoint through which more cost-effective care can be envisioned. Discovery of growth factor interactions with prostate cancer cells and the elucidation of apoptotic pathways have provided numerous new targets for biologic and chemotherapy of advanced disease.
Related Concept Videos
Treatment Resistent Cancers
Patient-centered Care
Kidney Transplant III: Nursing Management
Ethical Issues
Ethical Concerns in Healthcare:
Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing
This therapeutic technique can also be used when a patient brings up pertinent information during a health-related conversation. The...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...